CIAM
AKTX

Caitong International Asset Management’s Akari Therapeutics AKTX Stock Holding History

Caitong International Asset Management’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82 Buy
+8
New +$69 ﹤0.01% 2238

Other funds holding AKTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Caitong International Asset Management's AKTX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Akari Therapeutics (AKTX) in Q2 2026: 8 shares worth $82. The stake represents ﹤0.01% of the portfolio and ranks #2238 among its holdings.

3 funds tracked by Wall St. Rank hold AKTX as of Q2 2026.

  • Caitong International Asset Management held 8 shares of Akari Therapeutics worth $82 as of Q2 2026.
  • Akari Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Akari Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2238 holding.
  • 3 funds tracked by Wall St. Rank held Akari Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.